In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Janik MartinInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.ORCID 0009-0007-1638-1986 Veronika NeubauerInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.ORCID 0009-0009-3710-3568 Rebecca RittersbergerInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.ORCID 0009-0007-5104-4467 Simon TreitlerInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.
Patrick KoppInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.
Cemre GündayMyBiotech GmbH, Industriestraße 1 B, 66802 Überherrn, Germany.
Iman ShrimoInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.
Annabelle DabbarsInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.
Frank RosenauInstitute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.ORCID 0000-0002-9297-6419 Oliver Haedicke-PetersInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.
Katharina SchindowskiInstitute of Applied Biotechnology, University of Applied Science Biberach, Hubertus-Liebrecht-Strasse 35, 88400 Biberach, Germany.ORCID 0000-0003-2514-1654 Funding
Deutsche Forschungsgemeinschaft ZI-1143/HU441 (OlfacMuc)European Union's Horizon 2020 research and innovation program 721098 (N2B-patch)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biopharmaceuticsciliaepithelial airway modelinhaled drug deliverymonoclonal antibodiesprimary cell culturetherapeutic antibodies
Identifiers
PMID40284456
PMCPMC12030231
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390